Dipeptidyl Peptidase-4 Inhibition Potentiates Stimulated Growth Hormone Secretion and Vasodilation in Women.

about

Dipeptidyl Peptidase-4 Inhibition Potentiates Stimulated Growth Hormone Secretion and Vasodilation in Women.

Item

http://www.wikidata.org/entity/Q52686166

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Dipeptidyl Peptidase-4 Inhibit ...... ion and Vasodilation in Women.

@en

Dipeptidyl Peptidase-4 Inhibit ...... ion and Vasodilation in Women.

@nl

type

Item

label

Dipeptidyl Peptidase-4 Inhibit ...... ion and Vasodilation in Women.

@en

Dipeptidyl Peptidase-4 Inhibit ...... ion and Vasodilation in Women.

@nl

prefLabel

Dipeptidyl Peptidase-4 Inhibit ...... ion and Vasodilation in Women.

@en

Dipeptidyl Peptidase-4 Inhibit ...... ion and Vasodilation in Women.

@nl

P1476

Dipeptidyl Peptidase-4 Inhibit ...... ion and Vasodilation in Women.

@en

P2093

Chang Yu

http://www.w3.org/2001/XMLSchema#string

Hui Nian

http://www.w3.org/2001/XMLSchema#string

Jessica K Devin

http://www.w3.org/2001/XMLSchema#string

Jessica R Wilson

http://www.w3.org/2001/XMLSchema#string

Martin Bidlingmaier

http://www.w3.org/2001/XMLSchema#string

Nancy J Brown

http://www.w3.org/2001/XMLSchema#string

P2860

Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus

Growth hormone exerts acute vascular effects independent of systemic or muscle insulin-like growth factor I

Generation of growth hormone pulsatility in women: evidence against somatostatin withdrawal as pulse initiator.

The decreased growth hormone response to growth hormone releasing hormone in obesity is associated to cardiometabolic risk factors.

Central, peripheral and resistance arterial reactivity: fluctuates during the phases of the menstrual cycle.

Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.

Dipeptidyl-peptidase 4 inhibition and the vascular effects of glucagon-like peptide-1 and brain natriuretic peptide in the human forearm

Insights from growth hormone receptor blockade.

Effects of GLP-1 on forearm vasodilator function and glucose disposal during hyperinsulinemia in the metabolic syndrome

Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women.

P31

scholarly article

P356

10.1161/JAHA.117.008000

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29478970

http://www.w3.org/2001/XMLSchema#string

P932

5866333

http://www.w3.org/2001/XMLSchema#string